Compumedics Limited (ASX:CMP)
0.3550
-0.0200 (-5.33%)
Feb 5, 2026, 3:47 PM AEST
Compumedics Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 2.69 | 1.89 | 3.8 | 7.29 | 6.77 |
Cash & Short-Term Investments | 2.69 | 1.89 | 3.8 | 7.29 | 6.77 |
Cash Growth | 42.33% | -50.22% | -47.94% | 7.74% | 5.58% |
Accounts Receivable | 14.88 | 10.43 | 12.53 | 14.13 | 13.01 |
Other Receivables | 2.99 | 0.71 | 2.5 | 2.42 | 2.47 |
Receivables | 17.87 | 11.14 | 15.03 | 16.54 | 15.49 |
Inventory | 14.66 | 13.21 | 10.69 | 9.71 | 9.68 |
Total Current Assets | 35.22 | 26.24 | 29.52 | 33.55 | 31.93 |
Property, Plant & Equipment | 1.78 | 2.95 | 3.62 | 1.21 | 1.71 |
Long-Term Investments | 0.76 | 0.65 | 0.7 | - | - |
Long-Term Deferred Tax Assets | - | 0.35 | 1.1 | 0.5 | 0.82 |
Long-Term Deferred Charges | 16.59 | 10.16 | 6.24 | 6.45 | 4.08 |
Total Assets | 54.34 | 40.36 | 41.18 | 41.71 | 38.55 |
Accounts Payable | 8.64 | 4.37 | 5.26 | 4.74 | 4.45 |
Accrued Expenses | 4.28 | 3.93 | 3.71 | 3.51 | 3.15 |
Short-Term Debt | 13.17 | 6.98 | 7.23 | 6.01 | 4.4 |
Current Portion of Leases | 0.53 | 0.78 | 0.68 | 0.16 | 0.67 |
Current Income Taxes Payable | 0.18 | - | 0.09 | - | - |
Current Unearned Revenue | 1.53 | 1.34 | 2.69 | 1.92 | 1.75 |
Other Current Liabilities | 3.52 | 3.86 | 1.54 | 1.2 | 0.94 |
Total Current Liabilities | 31.85 | 21.25 | 21.19 | 17.54 | 15.35 |
Long-Term Debt | - | - | 0.21 | 0.38 | 0.59 |
Long-Term Leases | 0.18 | 0.83 | 1.36 | - | 0.16 |
Long-Term Unearned Revenue | 0.24 | 0.03 | 0.08 | 0.15 | 0.27 |
Pension & Post-Retirement Benefits | 0.03 | 0.04 | 0.07 | 0.05 | 0.02 |
Long-Term Deferred Tax Liabilities | 0.33 | - | - | - | - |
Total Liabilities | 32.63 | 22.15 | 22.89 | 18.12 | 16.39 |
Common Stock | 39.45 | 35.65 | 35.65 | 35.65 | 35.65 |
Retained Earnings | -18.58 | -17.31 | -17.79 | -11.67 | -13.03 |
Comprehensive Income & Other | 0.84 | -0.13 | 0.43 | -0.39 | -0.47 |
Shareholders' Equity | 21.71 | 18.21 | 18.29 | 23.59 | 22.16 |
Total Liabilities & Equity | 54.34 | 40.36 | 41.18 | 41.71 | 38.55 |
Total Debt | 13.88 | 8.58 | 9.47 | 6.55 | 5.82 |
Net Cash (Debt) | -11.19 | -6.69 | -5.67 | 0.75 | 0.95 |
Net Cash Growth | - | - | - | -21.47% | -41.10% |
Net Cash Per Share | -0.06 | -0.04 | -0.03 | 0.00 | 0.01 |
Filing Date Shares Outstanding | 192.22 | 183.77 | 177.16 | 177.16 | 177.16 |
Total Common Shares Outstanding | 192.22 | 177.16 | 177.16 | 177.16 | 177.16 |
Working Capital | 3.37 | 4.99 | 8.33 | 16.01 | 16.58 |
Book Value Per Share | 0.11 | 0.10 | 0.10 | 0.13 | 0.13 |
Tangible Book Value | 21.71 | 18.21 | 18.29 | 23.59 | 22.16 |
Tangible Book Value Per Share | 0.11 | 0.10 | 0.10 | 0.13 | 0.13 |
Machinery | 10.82 | 10.61 | 10.36 | 9.94 | 9.33 |
Leasehold Improvements | 1.08 | 1.13 | 1.07 | 0.61 | 0.61 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.